logo
  • Home
  • Solution
  • Impact
  • R&D
    • Science
    • Publications
    • STEP study
  • About
    • Team and Board
  • News and Events
    • All News
    • All Events
    • All Press Releases
  • Contact

News

Breakthrough results published in Science Translational Medicine

On January 1st the scientific article on the mechanisms and the effect of the wound gel was published in Science Translational Medicine, the highest ranked journal for translational medicine. The article was also chosen to be the cover story for this issue! This both shows the high quality of the work and that the science that Xinnate is based on is truly breakthrough.
Find the article using this link:

A dual-action peptide-containing hydrogel targets wound infection and inflammation - https://stm.sciencemag.org/content/12/524/eaax6601


by charlotta.walse@xinnate.com

A new article about BioC results from Lund University

Läs artikeln här! https://www.lu.se/article/nasta-generations-sarbehandling-under-utveckling


by charlotta.walse@xinnate.com

Recent Posts

  • Xinnate får FDAs Fast Track-status för TCP-25 vid behandling av epidermolysis bullosa
  • Xinnate receives FDA Fast Track Designation for TCP-25 for the Treatment of Epidermolysis Bullosa
  • The 3rd World Congress on Rare Skin Diseases: 01-03 July 2026
  • BIO International Convention: 22-25 June 2026
  • EADV Symposium 2026: 07-09 May 2026

Archives

  • June 2026
  • May 2026
  • February 2026
  • January 2026
  • December 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • January 2025
  • December 2024
  • September 2024
  • May 2024
  • March 2024
  • February 2024
  • March 2023
  • October 2022
  • September 2022
  • July 2022
  • March 2022
  • August 2021
  • October 2020
  • January 2020
  • 1
  • 2
  • 3
  • 4
© 2026 Xinnate. All rights reserved